GoodRx Reports Fourth Quarter and Full Year 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- Wall St climbs after August inflation report, oil price slide
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but on track for 8% weekly gain on supply concerns; US diesel hits record high
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- White House copper tariff plan stalls amid affordability concerns, sources say
- Micron's Taiwan workers to get rewards worth up to 68 months of pay
- Crude Inventory 0.4M Barrels Last Week - EIA
- Vertiv shares drop on acquisition skepticism, AI pullback
- S&P 500, Dow futures attempt recovery ahead of inflation report
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Raymond James Reiterates Strong Buy Rating on GoodRx Holdings Inc. (GDRX)
February 27, 2025 4:05 PM ESTRaymond James analyst Aaron Kessler reiterated a Strong Buy rating and $9.00 price target on GoodRx Holdings Inc. (NASDAQ: GDRX).
The analyst comments "All in all, it was a solid quarter, and we expect a more stable cadence of expectations/earnings... More
GoodRx Holdings Inc. (GDRX) PT Raised to $6.75 at Citi
February 27, 2025 3:15 PM ESTCiti analyst Daniel Grosslight raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $6.75 (from $6.25) while maintaining a Buy rating.
The analyst comments "After a couple quarters of excess volatility, GDRXs 4Q results should be a bit of a reprieve for... More
